Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Modest Increase in Patient Visits Could Offset Costs of Scribes
Model shows adding two new or three return patient visits per day profitable for all specialties
Time to Results Faster With Point-of-Care COVID-19 Testing
Time to results significantly shorter with QIAstat-Dx Respiratory SARS-CoV-2 Panel than with PCR
No Evidence Found of Vertical Transmission of SARS-CoV-2
Newborns of mothers with severe/critical COVID-19 born early, at risk for needing phototherapy
Telehealth Disparity Seen in Cancer Care
Black, Hispanic patients with cancer significantly less likely to use video telehealth versus White patients
NIH Launches Trial of Antibody Drugs Against COVID-19
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir
Glecaprevir and Pibrentasvir Aid HCV D+/R− Kidney Transplants
Two studies demonstrate safe transplant of kidneys from deceased donors with HCV infection
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Lack of Knowledge Barrier to Prone Positioning Use in ARDS
Implementation strategies developed included educational outreach, learning collaborative
Black Race Tied to COVID-19 Admissions, but Not Deaths
In-hospital mortality higher for Asian patients, despite lower risk for hospital admission
